Voleon Composition International Fund, Ltd. has filed an amendment to its previous offering, which is significant for the fund's ongoing operations and compliance with SEC regulations. This amendment reflects the fund's commitment to transparency and adherence to industry standards, particularly in the pooled investment fund sector.

Founded in the Cayman Islands, Voleon Composition International Fund is classified as a pooled investment fund under the SEC's regulations. The fund operates under the investment company act, specifically under sections 3(c)(7) and 506(b), which provide a framework for private offerings. The fund's latest filing, dated November 3, 2026, is part of its regular updates to maintain compliance with regulatory requirements.

The filing states that this amendment is an update to previous disclosures, with the last amendment filed on November 3, 2025. The document emphasizes that the fund is not a business combination transaction, and it continues to offer securities as a pooled investment fund type. The fund has not disclosed its aggregate net asset value range, indicating a strategic decision to keep certain financial details private.

Voleon Composition International Fund has reported a total amount sold of approximately $2.86 billion, with a minimum investment requirement set at $1 million. The fund currently has 165 investors, all of whom are accredited, which aligns with its strategy to focus on high-net-worth individuals and institutional investors. This move may positively influence investor confidence and attract further investments in the hedge fund sector.

As the fund continues to navigate the regulatory landscape, it is essential for stakeholders and potential investors to monitor its filings closely. The amendment indicates that Voleon Composition International Fund is committed to maintaining its operational integrity and compliance with SEC regulations.

The filing does not specify what happens next for the fund, but it is likely that further updates will follow as part of its ongoing regulatory obligations.